MyFinsight
Home
Blog
About
US
$3,426M
(6.27%↑ Y/Y)
Non Us
$2,017M
(9.80%↑ Y/Y)
Net sales
$5,442M
(7.53%↑ Y/Y)
Gross profit
$3,848M
(12.38%↑ Y/Y)
Cost of products sold
(excluding amortization...
$1,594M
(-2.63%↓ Y/Y)
Operating income (loss)
$1,178M
(43.83%↑ Y/Y)
Operating expenses
$2,670M
(2.50%↑ Y/Y)
Contingent consideration
net expense...
-$16M
(-220.00%↓ Y/Y)
Income (loss)before
income taxes
$1,060M
(12.65%↑ Y/Y)
Interest expense
$96M
(6.67%↑ Y/Y)
Other, net
-$23M
(-110.80%↓ Y/Y)
Selling, general and
administrative expenses
$1,803M
(5.07%↑ Y/Y)
Research and development
expenses
$554M
(5.32%↑ Y/Y)
Amortization expense
$233M
(3.56%↑ Y/Y)
Litigation-related net charges
(credits)
$76M
Royalty expense
$12M
(-14.29%↓ Y/Y)
Restructuring net charges
(credits)
$8M
(-90.36%↓ Y/Y)
Net income (loss)
$905M
(13.84%↑ Y/Y)
Net income (loss)
attributable to...
-$2M
(0.00%↑ Y/Y)
Income tax expense
(benefit)
$155M
(6.16%↑ Y/Y)
Net income (loss)
attributable to boston...
$907M
(13.80%↑ Y/Y)
Back
Back
Income Statement
safari-pinned-tab-svg
BOSTON SCIENTIFIC CORP (BSX)
safari-pinned-tab-svg
source: myfinsight.com
BOSTON SCIENTIFIC CORP (BSX)